Correlation Between BioNTech and Elevai Labs,

Can any of the company-specific risk be diversified away by investing in both BioNTech and Elevai Labs, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Elevai Labs, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Elevai Labs, Common, you can compare the effects of market volatilities on BioNTech and Elevai Labs, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Elevai Labs,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Elevai Labs,.

Diversification Opportunities for BioNTech and Elevai Labs,

-0.19

Correlation Coefficient

BioNTech  Elevai Labs,

Good diversification

The 3 months correlation between BioNTech and Elevai is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Elevai Labs, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevai Labs, Common and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Elevai Labs,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevai Labs, Common has no effect on the direction of BioNTech i.e., BioNTech and Elevai Labs, go up and down completely randomly.

Pair Corralation between BioNTech and Elevai Labs,

Given the investment horizon of 90 days BioNTech SE is expected to generate 0.25 times more return on investment than Elevai Labs,. However, BioNTech SE is 3.98 times less risky than Elevai Labs,. It trades about 0.06 of its potential returns per unit of risk. Elevai Labs, Common is currently generating about -0.24 per unit of risk. If you would invest  11,048  in BioNTech SE on October 25, 2024 and sell it today you would earn a total of  855.00  from holding BioNTech SE or generate 7.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioNTech SE  vs.  Elevai Labs, Common

BioNTech SE

Risk-Adjusted Performance

4 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Elevai Labs, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elevai Labs, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with BioNTech and Elevai Labs,

The main advantage of trading using opposite BioNTech and Elevai Labs, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Elevai Labs, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevai Labs, will offset losses from the drop in Elevai Labs,'s long position.

The idea behind BioNTech SE and Elevai Labs, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.